Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are also highly likely to have either underlying heart damage from heart failure and heart attacks, ...
Nov 17, 2022
0
1228
More than 8 million pounds of bisphenol A (BPA) is produced each year and reaches 90 percent of the population through consumer and medical products. Epidemiological studies find BPA exposure in adults correlate with adverse ...
May 14, 2018
2
86
A study led by Massachusetts General Hospital (MGH) and Icahn School of Medicine at Mount Sinai (ISSMS) investigators has linked, for the first time in humans, activity in a stress-sensitive structure within the brain to ...
Jan 11, 2017
0
533
A recent Mayo Clinic study examining the effects of daylight saving time (DST) on heart health suggests that the impact is likely minimal.
Feb 27, 2024
0
0
An intensive three-year intervention to lower the top blood pressure number to less than 120 mm Hg was more effective at preventing death, heart attack, stroke and other cardiovascular events in adults at high risk for cardiovascular ...
Nov 13, 2023
0
4
Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication ...
Aug 15, 2023
0
27
Adverse childhood experiences (ACEs) contribute to reduced vascular function and diminished sleep quality in young adults, according to a study at the University of Iowa. In addition, researchers found that poor sleep efficiency ...
Apr 21, 2023
0
15
For women, peripheral microvascular dysfunction in response to mental stress is associated with adverse cardiovascular events, according to a study published online March 1 in Atherosclerosis, Thrombosis, and Vascular Biology ...
Mar 3, 2023
0
2
The diameter of the thoracic aorta is a biomarker for heart attacks and other adverse cardiovascular events in women and men, according to a new study published in the journal Radiology.
Apr 12, 2022
0
10
(HealthDay)—For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based glucagon-like peptide ...
Jun 29, 2021
0
2
